共 28 条
[1]
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.[J] Ruggenenti Piero;Debiec Hanna;Ruggiero Barbara;Chianca Antonietta;Pellé Timothee;Gaspari Flavio;Suardi Flavio;Gagliardini Elena;Orisio Silvia;Benigni Ariela;Ronco Pierre;Remuzzi Giuseppe Journal of the American Society of Nephrology : JASN 2015,
[2]
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).[J] Fervenza Fernando C;Canetta Pietro A;Barbour Sean J;Lafayette Richard A;Rovin Brad H;Aslam Nabeel;Hladunewich Michelle A;Irazabal Maria V;Sethi Sanjeev;Gipson Debbie S;Reich Heather N;Brenchley Paul;Kretzler Matthias;Radhakrishnan Jai;Hebert Lee A;Gipson Patrick E;Thomas Leslie F;McCarthy Ellen T;Appel Gerald B;Jefferson J Ashley;Eirin Alfonso;Lieske John
[3]
Increasing frequency of idiopathic membranous nephropathy in primary glomerular disease: A 10‐year renal biopsy study from a single C hinese nephrology centre[J] Ping Zhu;Fu‐de Zhou;Su‐xia Wang;Ming‐hui Zhao;Hai‐yan Wang Nephrology 2015,
[4]
Rituximab in primary membranous nephropathy: first-line therapy; why not?[J] Cravedi Paolo;Remuzzi Giuseppe;Ruggenenti Piero Nephron. Clinical practice 2014,
[5]
Immunopathogenesis of membranous nephropathy: an update[J] Hanna Debiec;Pierre Ronco Seminars in Immunopathology 2014,
[6]
Thrombospondin Type-1 Domain-Containing 7A in Idiopathic Membranous Nephropathy[J] Nicola M. Tomas;Laurence H. Beck;Catherine Meyer-Schwesinger;Barbara Seitz-Polski;Hong Ma;Gunther Zahner;Guillaume Dolla;Elion Hoxha;Udo Helmchen;Anne-Sophie Dabert-Gay;Delphine Debayle;Michael Merchant;Jon Klein;David J. Salant;Rolf A.K. Stahl;Gérard Lambeau The New England Journal of Medicine 2014,
[7]
Ofatumumab for rituximab-resistant nephrotic syndrome.[J] Basu Biswanath The New England journal of medicine 2014,
[8]
Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: A phase 2 study[J] Per S. Sorensen;Steen Lisby;Richard Grove;Frederick Derosier;Steve Shackelford;Eva Havrdova;Jelena Drulovic;Massimo Filippi Neurology 2014,
[9]
Rituximab for the second- and third-line therapy of idiopathic membranous nephropathy: a prospective single center study using a new treatment strategy.[J] Busch Martin;Rüster Christiane;Schinköthe Claudia;Gerth Jens;Wolf Gunter Clinical nephrology 2013,
[10]
Changing spectrum of biopsy-proven primary glomerular diseases over the past 15 years: a single-center study in China.[J] Pan Xiaoxia;Xu Jing;Ren Hong;Zhang Wen;Xu Yaowen;Shen Pingyan;Li Xiao;Wang Weiming;Chen Xiaonong;Wu Pei;Feng Xiaobei;Hao Cuilan;Chen Nan Contributions to nephrology 2013,